These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31273195)

  • 21. The role of nacreous factors in preventing osteoporotic bone loss through both osteoblast activation and osteoclast inactivation.
    Kim H; Lee K; Ko CY; Kim HS; Shin HI; Kim T; Lee SH; Jeong D
    Biomaterials; 2012 Oct; 33(30):7489-96. PubMed ID: 22809648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice.
    Duque G; Huang DC; Dion N; Macoritto M; Rivas D; Li W; Yang XF; Li J; Lian J; Marino FT; Barralet J; Lascau V; Deschênes C; Ste-Marie LG; Kremer R
    J Bone Miner Res; 2011 Jul; 26(7):1472-83. PubMed ID: 21308779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schnurri-3 regulates BMP9-induced osteogenic differentiation and angiogenesis of human amniotic mesenchymal stem cells through Runx2 and VEGF.
    Li Y; Liu Z; Tang Y; Feng W; Zhao C; Liao J; Zhang C; Chen H; Ren Y; Dong S; Liu Y; Hu N; Huang W
    Cell Death Dis; 2020 Jan; 11(1):72. PubMed ID: 31996667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bone-targeting drug-delivery system based on Semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice.
    Yang K; Miron RJ; Bian Z; Zhang YF
    Bone; 2018 Sep; 114():40-49. PubMed ID: 29883786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target.
    Wei H; Xu Y; Wang Y; Xu L; Mo C; Li L; Shen B; Sun Y; Cheng P; Yang L; Pang Y; Qin A; Cao Y; Morrison SJ; Yue R
    Cell Rep; 2020 Oct; 33(2):108252. PubMed ID: 33053358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing miR-106b accelerates osteogenesis of mesenchymal stem cells and rescues against glucocorticoid-induced osteoporosis by targeting BMP2.
    Liu K; Jing Y; Zhang W; Fu X; Zhao H; Zhou X; Tao Y; Yang H; Zhang Y; Zen K; Zhang C; Li D; Shi Q
    Bone; 2017 Apr; 97():130-138. PubMed ID: 28108317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of Ac45 Simultaneously Inhibits Osteoclast-Mediated Bone Resorption and Attenuates Dendritic Cell-Mediated Inflammation through Impairing Acidification and Cathepsin K Secretion.
    Yang W; Zhu Z; Li L; McVicar A; Gao N; Wang L; Li YP; Chen W
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ac45 silencing mediated by AAV-sh-Ac45-RNAi prevents both bone loss and inflammation caused by periodontitis.
    Zhu Z; Chen W; Hao L; Zhu G; Lu Y; Li S; Wang L; Li YP
    J Clin Periodontol; 2015 Jul; 42(7):599-608. PubMed ID: 25952706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
    Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G
    Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss.
    Rucci N; Capulli M; Ventura L; Angelucci A; Peruzzi B; Tillgren V; Muraca M; Heinegård D; Teti A
    J Bone Miner Res; 2013 Sep; 28(9):1912-24. PubMed ID: 23559035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
    Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
    J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.
    Wu RW; Lian WS; Chen YS; Ko JY; Wang SY; Jahr H; Wang FS
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss.
    Shinohara M; Chang BY; Buggy JJ; Nagai Y; Kodama T; Asahara H; Takayanagi H
    Bone; 2014 Mar; 60():8-15. PubMed ID: 24316417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency.
    Shen S; Horowitz ED; Troupes AN; Brown SM; Pulicherla N; Samulski RJ; Agbandje-McKenna M; Asokan A
    J Biol Chem; 2013 Oct; 288(40):28814-23. PubMed ID: 23940044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation.
    Chung HJ; Cho L; Shin JS; Lee J; Ha IH; Park HJ; Lee SK
    BMC Complement Altern Med; 2014 Jun; 14():184. PubMed ID: 24903150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.
    Thaler R; Maurizi A; Roschger P; Sturmlechner I; Khani F; Spitzer S; Rumpler M; Zwerina J; Karlic H; Dudakovic A; Klaushofer K; Teti A; Rucci N; Varga F; van Wijnen AJ
    J Biol Chem; 2016 Mar; 291(13):6754-71. PubMed ID: 26757819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency.
    Mohan S; Kapoor A; Singgih A; Zhang Z; Taylor T; Yu H; Chadwick RB; Chung YS; Donahue LR; Rosen C; Crawford GC; Wergedal J; Baylink DJ
    J Bone Miner Res; 2005 Sep; 20(9):1597-610. PubMed ID: 16059632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.
    Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J
    Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in mice.
    Jin Q; Qiao C; Li J; Li J; Xiao X
    Gene Ther; 2020 May; 27(5):237-244. PubMed ID: 31819202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.